• 1
    Verhagen TE, Hendriks DJ, Bancsi LF, Mol BW, Broekmans FJ. The accuracy of multivariate models predicting ovarian reserve and pregnancy after in vitro fertilization: A meta-analysis. Hum Reprod Update 2008; 14: 95100.
  • 2
    Chang MY, Chiang CH, Hsieh TT, Soong YK, Hsu KH. Use of the antral follicle count to predict the outcome of assisted reproductive technologies. Fertil Steril 1998; 69: 505510.
  • 3
    Pellicer A, Ardiles G, Neuspiller F, Remohi J, Simon C, Bonilla-Musoles F. Evaluation of the ovarian reserve in young low responders with normal basal levels of follicle-stimulating hormone using three-dimensional ultrasonography. Fertil Steril 1998; 70: 671675.
  • 4
    Pellicer A, Gaitan P, Neuspiller F, Ardiles G, Albert C, Remohi J, Simon C. Ovarian follicular dynamics: From basic science to clinical practice. J Reprod Immunol 1998; 39: 2961.
  • 5
    Scheffer GJ, Broekmans FJ, Dorland M, Habbema JD, Looman CW, te Velde ER. Antral follicle counts by transvaginal ultrasonography are related to age in women with proven natural fertility. Fertil Steril 1999; 72: 845851.
  • 6
    Scheffer GJ, Broekmans FJ, Looman CW, Blankenstein M, Fauser BC, teJong FH, teVelde ER. The number of antral follicles in normal women with proven fertility is the best reflection of reproductive age. Hum Reprod 2003; 18: 700706.
  • 7
    Elgindy EA, El-Haieg DO, El-Sebaey A. Anti-mullerian hormone: Correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients. Fertil Steril 2008; 89: 16701676.
  • 8
    Kwee J, Schats R, McDonnell J, Themmen A, de Jong F, Lambalk C. Evaluation of anti-mullerian hormone as a test for the prediction of ovarian reserve. Fertil Steril 2008; 90: 737743.
  • 9
    Broekmans FJ, Visser JA, Laven JS, Broer SL, Themmen AP, Fauser BC. Anti-mullerian hormone and ovarian dysfunction. Trends Endocrinol Metab 2008; 19: 340347.
  • 10
    Broer SL, Mol B, Dolleman M, Fauser BC, Broekmans FJ. The role of anti-Müllerian hormone assessment in assisted reproductive technology outcome. Curr Opin Obstet Gynecol 2010; 22: 193201.
  • 11
    La Marca A, Giulini S, Tirelli A, Bertucci E, Marsella T, Xella S, Volpe A. Anti-Müllerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology. Hum Reprod 2007; 22: 766771.
  • 12
    van Rooij IA, Broekmans FJ, Scheffer GJ, Looman CW, Habbema JD, de Jong FH, Fauser BJ, Themmen AP, te Velde ER. Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: A longitudinal study. Fertil Steril 2005; 83: 979987.
  • 13
    Jayaprakasan K, Deb S, Batcha M, Hopkisson J, Johnson I, Campbell B, Raine-Fenning N. The cohort of antral follicles measuring 2-6 mm reflects the quantitative status of ovarian reserve as assessed by serum levels of anti-mullerian hormone and response to controlled ovarian stimulation. Fertil Steril 2010; 94: 17751781.
  • 14
    Hehenkamp WJ, Looman CW, Themmen AP, de Jong FH, Te Velde ER, Broekmans FJ. Anti-mullerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation. J Clin Endocrinol Metab 2006; 91: 40574063.
  • 15
    La Marca A, Stabile G, Artenisio AC, Volpe A. Serum anti-mullerian hormone throughout the human menstrual cycle. Hum Reprod 2006; 21: 31033107.
  • 16
    van Disseldorp J, Lambalk CB, Kwee J, Looman CW, Eijkemans MJ, Fauser BC, Broekmans FJ. Comparison of inter- and intra-cycle variability of anti-mullerian hormone and antral follicle counts. Hum Reprod 2010; 25: 221227.
  • 17
    Tsepelidis S, Devreker F, Demeestere I, Flahaut A, Gervy C, Englert Y. Stable serum levels of anti-mullerian hormone during the menstrual cycle: A prospective study in normo-ovulatory women. Hum Reprod 2007; 22: 18371840.
  • 18
    Cook CL, Siow Y, Taylor S, Fallat ME. Serum mullerian-inhibiting substance levels during normal menstrual cycles. Fertil Steril 2000; 73: 859861.
  • 19
    Eldar-Geva T, Ben-Chetrit A, Spitz IM, Rabinowitz R, Markowitz E, Mimoni T, Gal M, Zylber-Haran E, Margalioth EJ. Dynamic assays of inhibin B, anti-mullerian hormone and estradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outcome. Hum Reprod 2005; 20: 31783183.
  • 20
    Wunder DM, Bersinger NA, Yared M, Kretschmer R, Birkhauser MH. Statistically significant changes of antimullerian hormone and inhibin levels during the physiologic menstrual cycle in reproductive age women. Fertil Steril 2008; 89: 927933.
  • 21
    Jayaprakasan K, Campbell BK, Clewes JS, Johnson IR, Raine-Fenning NJ. Three-dimensional ultrasound improves the interobserver reliability of antral follicle counts and facilitates increased clinical work flow. Ultrasound Obstet Gynecol 2008; 31: 439444.
  • 22
    Jayaprakasan K, Walker KF, Clewes JS, Johnson IR, Raine-Fenning NJ. The interobserver reliability of off-line antral follicle counts made from stored three-dimensional ultrasound data: a comparative study of different measurement techniques. Ultrasound Obstet Gynecol 2007; 29: 335341.
  • 23
    Scheffer GJ, Broekmans FJ, Bancsi LF, Habbema JD, Looman CW, Te Velde ER. Quantitative transvaginal two- and three-dimensional sonography of the ovaries: reproducibility of antral follicle counts. Ultrasound Obstet Gynecol 2002; 20: 270275.
  • 24
    Deb S, Jayaprakasan K, Campbell BK, Clewes JS, Johnson IR, Raine-Fenning NJ. Intraobserver and interobserver reliability of automated antral follicle counts made using three-dimensional ultrasound and SonoAVC. Ultrasound Obstet Gynecol 2009; 33: 477483.
  • 25
    Deb S, Campbell BK, Clewes JS, Raine-Fenning NJ. Quantitative analysis of antral follicle number and size: a comparison of two-dimensional and automated three-dimensional ultrasound techniques. Ultrasound Obstet Gynecol 2010; 35: 354360.
  • 26
    Deb S, Batcha M, Campbell BK, Jayaprakasan K, Clewes JS, Hopkisson JF, Sjoblom C, Raine-Fenning NJ. The predictive value of the automated quantification of the number and size of small antral follicles in women undergoing ART. Hum Reprod 2009; 24: 21242132.
  • 27
    Raine-Fenning N, Jayaprakasan K, Clewes J, Joergner I, Bonaki SD, Chamberlain S, Devlin L, Priddle H, Johnson I. SonoAVC: a novel method of automatic volume calculation. Ultrasound Obstet Gynecol 2008; 31: 691696.
  • 28
    Raine-Fenning N, Jayaprakasan K, Chamberlain S, Devlin L, Priddle H, Johnson I. Automated measurements of follicle diameter: A chance to standardize? Fertil Steril 2009; 91: 14691472.
  • 29
    Raine-Fenning N, Campbell B, Collier J, Brincat M, Johnson I. The reproducibility of endometrial volume acquisition and measurement with the VOCAL-imaging program. Ultrasound Obstet Gynecol 2002; 19: 6975.
  • 30
    Gougeon A. Some aspects of the dynamics of ovarian follicular growth in the human. Acta Eur Fertil 1989; 20: 185192.
  • 31
    Gougeon A. Regulation of ovarian follicular development in primates: facts and hypotheses. Endocr Rev 1996; 17: 121155.
  • 32
    Tsepelidis S, Demeestere I, Delbaere A, Gervy C, Englert Y. [anti-mullerian hormone and its role in the regulation of ovarian function. Review of the literature]. Rev Med Brux 2007; 28: 165171.
  • 33
    Elter K, Sismanoglu A, Durmusoglu F. Intercycle variabilities of basal antral follicle count and ovarian volume in subfertile women and their relationship to reproductive aging: A prospective study. Gynecol Endocrinol 2005; 20: 137143.
  • 34
    Jayaprakasan K, Campbell B, Hopkisson J, Clewes J, Johnson I, Raine-Fenning N. Establishing the intercycle variability of three-dimensional ultrasonographic predictors of ovarian reserve. Fertil Steril 2008; 90: 21262132.
  • 35
    Gougeon A. [intragonadal regulation of human follicular genesis: Facts and hypotheses]. Ann Endocrinol (Paris) 1994; 55: 6373.